Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1970 May;29(3):236–243. doi: 10.1136/ard.29.3.236

Procainamide-induced systemic lupus erythematosus.

P J Sheldon, W R Williams
PMCID: PMC1031257  PMID: 4194201

Full text

PDF
236

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkins C. J., Hamilton E. B. Procainamide-induced systemic lupus erythematosus. Proc R Soc Med. 1969 Feb;62(2):197–198. doi: 10.1177/003591576906200232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blomgren S. E., Condemi J. J., Bignall M. C., Vaughan J. H. Antinuclear antibody induced by procainamide. A prospective study. N Engl J Med. 1969 Jul 10;281(2):64–66. doi: 10.1056/NEJM196907102810203. [DOI] [PubMed] [Google Scholar]
  3. Bole G. G., Jr, Friedlaender M. H., Smith C. K. Rheumatic symptoms and serological abnormalities induced by oral contraceptives. Lancet. 1969 Feb 15;1(7590):323–326. doi: 10.1016/s0140-6736(69)91294-x. [DOI] [PubMed] [Google Scholar]
  4. Byrd R. B., Schanzer B. Pulmonary sequelae in procaine amide induced lupus-like syndrome. Dis Chest. 1969 Feb;55(2):170–172. doi: 10.1378/chest.55.2.170. [DOI] [PubMed] [Google Scholar]
  5. COLMAN R. W., STURGILL B. C. LUPUS-LIKE SYNDROME INDUCED BY PROCAINE AMIDE: ASSOCIATION WITH ANTI-DNA ANTIBODY. Arch Intern Med. 1965 Feb;115:214–216. doi: 10.1001/archinte.1965.03860140094021. [DOI] [PubMed] [Google Scholar]
  6. Carabia A. G., Fortney T. G., Jr Case report: lupus-like syndrome with positive Hargrave phenomenon induced by pronestyl therapy: analysis of the test. J Tenn Med Assoc. 1965 Sep;58(9):287–289. [PubMed] [Google Scholar]
  7. Compton-Smith R. N., Fawcett J. W. Systemic lupus erythematosus associated with procainamide. Br J Clin Pract. 1967 May;21(5):248–251. [PubMed] [Google Scholar]
  8. Dubois E. L. Procainamide induction of a systemic lupus erythematosus-like syndrome. Presentation of six cases, review of the literature, and analysis and followup of reported cases. Medicine (Baltimore) 1969 May;48(3):217–228. [PubMed] [Google Scholar]
  9. Fakhro A. M., Ritchie R. F., Lown B. Lupus-like syndrome induced by procainamide. Am J Cardiol. 1967 Sep;20(3):367–373. doi: 10.1016/0002-9149(67)90060-4. [DOI] [PubMed] [Google Scholar]
  10. HAHN A. L. SYSTEMIC LUPUS ERYTHEMATOSUS ASSOCIATED WITH PROCAINAMIDE THERAPY. Mo Med. 1964 Jan;61:19–PASSIM. [PubMed] [Google Scholar]
  11. HOLLEY H. L. EVIDENCE FOR A PREDISPOSITION TO RHEUMATIC DISEASES IN FAMILIES OF PATIENTS DEVELOPING DRUG-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS. Arthritis Rheum. 1964 Dec;7:684–686. doi: 10.1002/art.1780070608. [DOI] [PubMed] [Google Scholar]
  12. Hanlon T. M., Binkiewicz A., Feingold M., Necheles T. F. Procainamide HCl-induced lupus syndrome in a child with myotonia congenita. Am J Dis Child. 1967 Apr;113(4):491–493. doi: 10.1001/archpedi.1967.02090190137019. [DOI] [PubMed] [Google Scholar]
  13. KAPLAN J. M., WACHTEL H. L., CZARNECKI S. W., SAMPSON J. J. LUPUS-LIKE ILLNESS PRECIPITATED BY PROCAINAMIDE HYDROCHLORIDE. JAMA. 1965 May 10;192:444–447. doi: 10.1001/jama.1965.03080190010003. [DOI] [PubMed] [Google Scholar]
  14. LADD A. T. Procainamide-induced lupus erythematosus. N Engl J Med. 1962 Dec 27;267:1357–1358. doi: 10.1056/NEJM196212272672608. [DOI] [PubMed] [Google Scholar]
  15. Lappat E. J., Cawein M. J. A familial study of procainamide-induced systemic lupus erythematosus. A question of pharmacogenetic polymorphism. Am J Med. 1968 Dec;45(6):846–852. doi: 10.1016/0002-9343(68)90183-6. [DOI] [PubMed] [Google Scholar]
  16. Lee S. L., Rivero I., Siegel M. Activation of systemic lupus erythematosus by drugs. Arch Intern Med. 1966 May;117(5):620–626. [PubMed] [Google Scholar]
  17. London B. L., Pincus I. Reversible lupus-like illness induced by procainamide. Am Heart J. 1966 Dec;72(6):806–808. doi: 10.1016/0002-8703(66)90164-5. [DOI] [PubMed] [Google Scholar]
  18. McDevitt D. G., Glascow J. F. Lupus-like syndrome induced by procainamide. Br Med J. 1967 Sep 23;3(5568):780–781. doi: 10.1136/bmj.3.5568.780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Mehta B. R. Lupus-like syndrome after procainamide. Hawaii Med J. 1968 Nov-Dec;28(2):120–121. [PubMed] [Google Scholar]
  20. Oster Z. H. Agranulocytosis and lupus erythematosus phenomenon after procaine amide. Isr J Med Sci. 1966 May-Jun;2(3):354–355. [PubMed] [Google Scholar]
  21. PETERSON R. D., GOOD R. A. Interrelationships of the mesenchymal diseases with consideration of possible genetic mechanisms. Annu Rev Med. 1963;14:1–40. doi: 10.1146/annurev.me.14.020163.000245. [DOI] [PubMed] [Google Scholar]
  22. Paine R. Procainamide hydrochloride and lupus erythematosus. JAMA. 1965 Oct 4;194(1):23–26. [PubMed] [Google Scholar]
  23. Prockop L. D. Myotonia, procaine amide, and lupus-like syndrome. Arch Neurol. 1966 Mar;14(3):326–330. doi: 10.1001/archneur.1966.00470090098014. [DOI] [PubMed] [Google Scholar]
  24. Rosin J. M. Vasculitis following procaine amide therapy. Am J Med. 1967 Apr;42(4):625–629. doi: 10.1016/0002-9343(67)90062-9. [DOI] [PubMed] [Google Scholar]
  25. Russell A. S., Ziff M. Natural antibodies to procaine amide. Clin Exp Immunol. 1968 Nov;3(9):901–909. [PMC free article] [PubMed] [Google Scholar]
  26. Rutherford B. D. Procainamide-induced systemic lupus erythematosus. N Z Med J. 1968 Oct;68(437):235–240. [PubMed] [Google Scholar]
  27. Sanford H. S., Michaelson A. K., Halpern M. M. Procainamide induced lupus erythematosus syndrome. Dis Chest. 1967 Feb;51(2):172–176. doi: 10.1378/chest.51.2.172. [DOI] [PubMed] [Google Scholar]
  28. Schleicher E. M. L.E. cells after oral contraceptives. Lancet. 1968 Apr 13;1(7546):821–822. doi: 10.1016/s0140-6736(68)92271-x. [DOI] [PubMed] [Google Scholar]
  29. Skipworth G. B., Morris J. B., Goldstein N. Bilateral Mondor's disease. Arch Dermatol. 1967 Jan;95(1):95–97. [PubMed] [Google Scholar]
  30. Torrigiani G., Ansell B. M., Chown E. E., Roitt I. M. Raised IgG antiglobulin factors in Still's disease. Ann Rheum Dis. 1969 Jul;28(4):424–427. doi: 10.1136/ard.28.4.424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. ZINKHAM W. H., CONLEY C. L. Some factors influencing the formation of L.E. cells; a method for enhancing L.E. cell production. Bull Johns Hopkins Hosp. 1956 Feb;98(2):102–119. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES